Brady Kathleen T, McCauley Jenna L, Back Sudie E
From the Addiction Sciences Division, Institute of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston; and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston.
Am J Psychiatry. 2016 Jan;173(1):18-26. doi: 10.1176/appi.ajp.2015.15020262. Epub 2015 Sep 4.
Prescription opioid abuse and dependence have escalated rapidly in the United States over the past 20 years, leading to high rates of overdose deaths and a dramatic increase in the number of people seeking treatment for opioid dependence. The authors review the scope of the abuse and overdose epidemic, prescription practices, and the assessment, treatment, and prevention of prescription opioid misuse and dependence.
The authors provide an overview of the literature from 2006 to the present, with the twin goals of highlighting advances in prevention and treatment and identifying remaining gaps in the science.
A number of policy and educational initiatives at the state and federal government level have been undertaken in the past 5 years to help providers and consumers, respectively, prescribe and use opioids more responsibly. Initial reports suggest that diversion and abuse levels have begun to plateau, likely as a result of these initiatives. While there is a large body of research suggesting that opioid substitution coupled with psychosocial interventions is the best treatment option for heroin dependence, there is limited research focusing specifically on the treatment of prescription opioid dependence. In particular, the treatment of chronic pain in individuals with prescription opioid use disorders is underexplored.
While policy and educational initiatives appear to be effective in decreasing prescription opioid abuse and misuse, research focusing on the development and evaluation of treatments specific to prescription opioid dependence and its common comorbidities (e.g., chronic pain, depression) is critically needed.
在过去20年里,美国处方阿片类药物滥用和依赖情况迅速升级,导致过量用药死亡率居高不下,寻求阿片类药物依赖治疗的人数急剧增加。作者回顾了滥用和过量用药流行情况的范围、处方实践以及处方阿片类药物滥用和依赖的评估、治疗及预防。
作者概述了2006年至今的文献,目标有两个,一是突出预防和治疗方面的进展,二是找出科学研究中仍存在的差距。
在过去5年里,州和联邦政府层面采取了多项政策和教育举措,分别帮助医疗服务提供者和消费者更负责任地开具和使用阿片类药物。初步报告显示,由于这些举措,药物转移和滥用水平可能已开始趋于平稳。虽然有大量研究表明,阿片类药物替代疗法与心理社会干预相结合是治疗海洛因依赖的最佳选择,但专门针对处方阿片类药物依赖治疗的研究有限。特别是,针对患有处方阿片类药物使用障碍的个体的慢性疼痛治疗研究不足。
虽然政策和教育举措似乎在减少处方阿片类药物滥用和误用方面有效,但迫切需要开展针对处方阿片类药物依赖及其常见合并症(如慢性疼痛、抑郁症)的治疗方法开发和评估的研究。